Position in HLN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,261
-$609 QoQ
Shares Held
126
-31.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026NFSG Corp holds $109,838 across 12 Drug Manufacturers - Specialty & Generic names. HLN ranks #8 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
600 | $46,140 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
700 | $21,084 | |
| 3 | VTRS |
Viatris Inc
|
1,132 | $15,293 | |
| 4 | ZTS |
Zoetis Inc.
|
99 | $11,702 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
10 | $5,929 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
260 | $5,397 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
500 | $2,075 | |
| 8 | HLN |
Haleon plc
This page
|
126 | $1,261 |
All Filings in HLN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,261 | 126 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,870 | 185 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,130 | 126 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,306 | 126 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $1,296 | 126 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,240 | 130 | Shares | Sole | 2025-01-28 | |
| 2022-12-31 | $3,200 | 400 | Shares | Sole | 2023-01-17 | |
| No filing history on record for this holder in this stock. | ||||||